Search - Université de Rennes Access content directly

Filter your results

16 Results
authFullName_s : Guillaume Manson
Image document

Long-term efficacy of anti-PD1 therapy in Hodgkin lymphoma with and without allogenic stem cell transplantation

Guillaume Manson , Jean-Baptiste Mear , Charles Herbaux , Jean-Marc Schiano , Olivier Casasnovas et al.
European Journal of Cancer, 2019, 115, pp.47-56. ⟨10.1016/j.ejca.2019.04.006⟩
Journal articles hal-02134578v1

Checkpoint blockade after kidney transplantation

Mathieu Lesouhaitier , Caroline Dudreuilh , Mathilde Tamain , Nada Kanaan , Elodie Bailly et al.
European Journal of Cancer, 2018, 96, pp.111-114. ⟨10.1016/j.ejca.2018.03.019⟩
Journal articles hal-01795812v1

Performance of CT Compared with F-FDG PET in Predicting the Efficacy of Nivolumab in Relapsed or Refractory Hodgkin Lymphoma

Fatima-Zohra Mokrane , Aiping Chen , Lawrence H Schwartz , Franck Morschhauser , Apasia Stamatoullas et al.
Radiology, 2020, 295 (3), pp.651-661. ⟨10.1148/radiol.2020192056⟩
Journal articles hal-02569415v1
Image document

Can nivolumab alone cure patients with relapse or refractory Hodgkin lymphoma? A 5-year analysis of the French early access program (EPA)

Guillaume Manson , Charles Herbaux , Jean Marc Schiano de Colella , René-Olivier Casasnovas , Aspasia Stamatoullas et al.
British Journal of Haematology, 2022, 198 (1), pp.203-206. ⟨10.1111/bjh.18198⟩
Journal articles hal-03665134v1
Image document

Prolonged thrombocytopenia after CAR T-cell therapy: the role of thrombopoietin receptor agonists

Gaëlle Drillet , Faustine Lhomme , Sophie de Guibert , Guillaume Manson , Roch Houot et al.
Journal articles hal-03901600v1
Image document

Interpretation of 2-[F-18]FDG PET/CT in Hodgkin lymphoma patients treated with immune checkpoint inhibitors

Guillaume Manson , Amaeshi Chukwunonye Lemchukwu , Fatima-Zohra Mokrane , Egesta Lopci , Nicolas Aide et al.
European Radiology, 2022, 32, pp.6536-6544. ⟨10.1007/s00330-022-08669-8⟩
Journal articles hal-03665222v1

Superiority of Allogenic Stem Cell Transplantation after Anti-PD1 Therapy over Anti-PD1 Monotherapy Alone in Relapse/Refractory Hodgkin Lymphoma Real World Evidence from the French Early Access Program

Roch Houot , Guillaume Manson , Jean-Baptiste Mear , Charles Herbaux , Jean Marc Schiano de Collela et al.
Blood, 2018, 132 (1), pp.1638. ⟨10.1182/blood-2018-99-110960⟩
Journal articles hal-02076926v1

Nivolumab Is Effective and Reasonably Safe in Relapsed or Refractory Hodgkin's Lymphoma after Allogeneic Hematopoietic Cell Transplantation: A Study from the Lysa and SFGM-TC

Loic Ysebaert , Roch Houot , Ibrahim Yakoub-Agha , Franck Morschhauser , Charles Herbaux et al.
Blood, 2015, 126 (23), pp.3979-3979
Journal articles hal-01290424v1
Image document

Unconventional immune-related phenomena observed using 18F-FDG PET/CT in Hodgkin lymphoma treated with anti PD-1 monoclonal antibodies

Laurent Dercle , Fatima-Zohra Mokrane , Jean Marc Schiano de Colella , Apasia Stamatoullas , Franck Morschhauser et al.
European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 (6), pp.1391-1392. ⟨10.1007/s00259-019-04310-x⟩
Journal articles hal-02119287v1

Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma

Reid Merryman , Luca Castagna , Laura Giordano , Vincent Ho , Paolo Corradini et al.
Leukemia, 2021, 35 (9), pp.2672-2683. ⟨10.1038/s41375-021-01193-6⟩
Journal articles hal-03229516v1
Image document

Prolonged remissions after anti-PD1 discontinuation in patients with Hodgkin lymphoma

Guillaume Manson , Charles Herbaux , Pauline Brice , Krimo Bouabdallah , Aspasia Stamatoullas et al.
Blood, 2018, 131 (25), pp.2856-2859. ⟨10.1182/blood-2018-03-841262⟩
Journal articles hal-01812478v1
Image document

Early F-FDG PET/CT response predicts survival in Relapsed/Refractory Hodgkin Lymphoma treated with Nivolumab

Aiping Chen , Fatima-Zohra Mokrane , Lawrence Schwartz , Franck Morschhauser , Apasia Stamatoullas et al.
Journal of Nuclear Medicine, 2020, 61 (5), pp.649-654. ⟨10.2967/jnumed.119.232827⟩
Journal articles hal-02364994v1

Emerging and Evolving Concepts in Cancer Immunotherapy Imaging

Laurent Dercle , Shawn Sun , Romain-David Seban , Ahmed Mekki , Roger Sun et al.
Radiology, 2023, 306 (1), pp.32-46. ⟨10.1148/radiol.210518⟩
Journal articles hal-04093561v1
Image document

Hair Repigmentation With Anti-PD-1 and Anti-PD-L1 Immunotherapy: A Novel Hypothesis

Guillaume Manson , Aurélien Marabelle , Roch Houot
Journal of the American Medical Association, 2018, 154 (1), pp.113. ⟨10.1001/jamadermatol.2017.4421⟩
Journal articles hal-01699247v1

High-Dimensional Phenotyping of Human Myeloid-Derived Suppressor Cells/Tumor-Associated Macrophages in Tissue by Mass Cytometry

Juliette Ferrant , Simon Le Gallou , Guillaume Manson , Steve Genebrier , Frédéric Mourcin et al.
Methods in Molecular Biology, 2021, 2236, pp.57-66. ⟨10.1007/978-1-0716-1060-2_6⟩
Journal articles hal-03099418v1
Image document

Efficacy of anti-PD1 re-treatment in patients with Hodgkin lymphoma who relapsed after anti-PD1 discontinuation

Guillaume Manson , Pauline Brice , Charles Herbaux , Kamal Bouabdallah , Chloé Antier et al.
Haematologica, 2020, 105 (11), pp.2664-2666. ⟨10.3324/haematol.2019.242529⟩
Journal articles hal-02485796v1